Literature DB >> 21838213

Inferior oblique transposition onto the equator: the role of the equator in development of contralateral inferior oblique overaction.

Seung-Hyun Kim1, Jae-Hoon Na, Yoonae A Cho.   

Abstract

PURPOSE: To investigate the role of the location of the equator and orientation of newly attached inferior oblique (IO) muscle in the development of contralateral inferior oblique overaction (IOOA).
METHODS: Fourteen patients (14 eyes) with 5 to 12 prism diopters (PD) of hyperdeviation in primary position with unilateral, congenital, superior oblique palsy were included. Seven patients underwent modified IO transposition onto the equator (equator group) and seven patients underwent modified IO 14-mm recession (14-mm group). IOOA in the contralateral eye and the angle of strabismus were assessed at 3 months postoperatively.
RESULTS: Mean angles of hyperdeviation in primary gaze and sursoadduction were 0.7 and 2.1 PD in the equator group and 0.6 and 2.4 PD in the 14-mm group, respectively. Six patients (86%) developed anti-elevation syndrome and four patients (57%) showed definite 2+ or higher IOOA in the contralateral eye in the equator group. Three patients (43%) in the 14-mm group also developed contralateral IOOA, although it was 1+ or less. The postoperative difference in contra-lateral IOOA between groups was statistically significant (P = .04).
CONCLUSION: This finding suggests that vertical orientation of the IO muscle is another important contributor in the development of contralateral IOOA in addition to the location of the newly attached IO muscle. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21838213     DOI: 10.3928/01913913-20110809-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  1 in total

1.  A Valid Indication and the Effect of Bilateral Inferior Oblique Transposition on Recurrent or Consecutive Horizontal Deviation in Infantile Strabismus.

Authors:  Suk-Gyu Ha; Gun-Hoo Na; Seung-Hyun Kim
Journal:  Korean J Ophthalmol       Date:  2017-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.